Lilly rolls out its first-ever TV campaign for a cancer drug
The ads for the metastatic breast cancer drug Verzenio show women in their 50s and 60s looking resolute and indomitable, surrounded by smiling friends and family.
Health Care & Insurance
Articles
Antidote for opioid overdoses often is difficult to obtain
The fact naloxone is a prescription drug creates a hurdle for addicts and their families. In addition, many pharmacies and local health departments don’t stock it, and not everyone can afford it.
Baldwin & Lyons ekes out profit despite higher accident claims
Carmel-based insurer Baldwin & Lyons Inc. saw a big increase in revenue and premiums written in the first quarter, but a jump in accident losses almost wiped out earnings.
Bid of $6.5B for Athenahealth might be ploy to lure other bidders, including Anthem
Shares in Athenahealth Inc. surged the most since 2016 after activist investor Elliott Management Corp. bid to acquire the medical company for $160 a share.
Indiana officials aim to expand drug treatment programs
State officials said Thursday that they plan to fight Indiana’s opioid crisis by increasing capacity of state-sponsored drug treatment, promoting a campaign on reducing the stigma surrounding drug addiction and treatment, and training more health care workers.
Crawfordsville startup CorVus fattens pigs for science
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.
Major health initiative targets 3 Indianapolis neighborhoods with high diabetes rates
A five-year, $7 million program is led and supported by a coalition of local health institutions, including Eli Lilly and Co., Fairbanks School of Public Health and Eskenazi Health. It is based on a model that Lilly has used in other countries.
New Indiana program addresses maternal opioid crisis
The program at Community Hospital East in Indianapolis will have nearly $600,000 state grant money in place to curb the number of female addicts, whose babies often are addicted to drugs.
Eli Lilly’s next big push likely to come in pain treatments
The Indianapolis-based drugmaker has several pain medications in the pipeline, including potential treatments for migraine headaches, arthritis and chronic back pain.
Private equity firms mull bids for Eli Lilly’s Elanco unit
The Indianapolis pharmaceutical giant is evaluating whether to keep the division, which makes animal-health products, or sell it or take it public. An analyst said it might fetch $16 billion.
Anthem’s earnings jump 30 percent on lower medical expenses
Indianapolis-based insurer Anthem Inc. hiked its 2018 forecast after it topped Wall Street expectations with its first quarter performance.
IU School of Medicine leader finalist for new job in Oregon
Dr. Jay Hess is one of three finalists to become president at Oregon Health & Science University in Portland, according to The Oregonian.
Eli Lilly hikes forecast after better-than-expected first quarter
Indianapolis-based Eli Lilly and Co. on Tuesday reported quarterly revenue and adjusted earnings that exceeded analyst forecasts.
Drug industry sets lobbying records as pricing pressure looms
The drug industry set several quarterly records for lobbying spending in the first three months of 2018, but Indianapolis-based Eli Lilly and Co. actually reduced lobbying expenditures.
Indiana gets another $11M to combat heroin, opioid abuse
The Health and Human Services funding is among $485 million recently awarded nationwide to combat heroin and opioid abuse.
Cigna-Express Scripts deal to face Justice Department review
Cigna Corp. confirmed that its proposed $54 billion acquisition of Express Scripts Holding Co. will be reviewed by the U.S. Department of Justice, which has raised the bar for approving deals that don’t combine direct competitors.
HHS secretary Alex Azar hires Indy insurance exec in key advisory role
Health and Human Services Secretary Alex Azar, a former Eli Lilly and Co. executive who was hospitalized twice this week, has hired Jim Parker, president and CEO of MDwise and a former longtime executive at Anthem Inc.
Americans filling far fewer opioid prescriptions, new report says
The number of prescriptions for opioid painkillers filled in the United States fell dramatically last year, showing their biggest drop in 25 years.
Mainstreet retools, says old strategy ‘broke down’
For more than a decade, Zeke Turner built scores of senior-care facilities. But in the past year, Mainstreet has been reeling from an unexpected slowdown in sales of its properties.
St. Vincent rethinks how to deliver care; struggling parent cuts costs
Jonathan Nalli has a message for his 16,000 employees at St. Vincent Health: Get ready for more transformation and disruption.